14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 3rd May 2024 ALNY stock ended at $152.33. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41.
90 days $141.98 $173.18
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jan 19, 2022 $141.27 $144.18 $137.69 $138.62 475 000
Jan 18, 2022 $145.65 $147.01 $138.61 $139.19 647 500
Jan 14, 2022 $147.78 $152.42 $142.69 $148.50 457 100
Jan 13, 2022 $147.47 $150.82 $144.97 $148.00 606 300
Jan 12, 2022 $146.89 $149.47 $144.01 $147.54 750 400
Jan 11, 2022 $151.11 $152.12 $146.33 $148.03 674 100
Jan 10, 2022 $146.16 $150.17 $142.51 $150.16 841 200
Jan 07, 2022 $151.00 $153.30 $147.41 $148.13 594 200
Jan 06, 2022 $156.19 $156.19 $146.31 $151.00 1 122 400
Jan 05, 2022 $161.57 $163.28 $154.59 $155.09 886 800
Jan 04, 2022 $172.05 $174.66 $161.58 $165.23 826 080
Jan 03, 2022 $171.06 $174.00 $165.58 $173.91 988 173
Dec 31, 2021 $171.62 $175.32 $169.58 $169.58 381 809
Dec 30, 2021 $169.74 $174.50 $168.97 $171.03 675 010
Dec 29, 2021 $169.90 $170.36 $165.27 $170.08 557 739
Dec 28, 2021 $161.43 $171.99 $161.11 $168.70 1 207 081
Dec 27, 2021 $190.00 $190.00 $159.11 $161.11 4 522 990
Dec 23, 2021 $189.18 $196.30 $185.94 $194.35 390 372
Dec 22, 2021 $189.13 $193.75 $184.02 $187.38 1 240 197
Dec 21, 2021 $199.00 $199.88 $196.29 $199.59 1 174 858
Dec 20, 2021 $195.19 $199.50 $190.52 $198.29 1 526 165
Dec 17, 2021 $183.90 $195.80 $180.00 $194.57 959 204
Dec 16, 2021 $186.57 $190.54 $180.88 $184.88 560 511
Dec 15, 2021 $185.73 $194.10 $184.75 $191.06 760 079
Dec 14, 2021 $186.27 $190.06 $183.11 $185.73 658 494
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT